Open AccessRisk Factors that Predict Levothyroxine Medication after Thyroid Lobectomy
Author(s) -
Huai-dong Song,
C J Kim,
S Lee,
Ja Seong Bae,
Chan Kwon Jung,
Joon Jang
Publication year - 2020
Publication title -
acta endocrinologica (bucharest)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.249
H-Index - 13
eISSN - 1843-066X
pISSN - 1841-0987
DOI - 10.4183/aeb.2020.454
Subject(s) - levothyroxine , medicine , thyroid , thyroidectomy , hormone , risk factor
The risk of needing lifelong thyroid hormone supplementation is an important factor affecting treatment decisions for both patients and clinicians ahead thyroid lobectomy. The purposes of this study were to assess the predictive factors of levothyroxine medication after thyroid lobectomy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom